Crispr Therapeutics price target lowered to $55 from $63 at Citi

March 20, 2023

Must read

Crispr Therapeutics price target lowered to $55 from $63 at Citi

Source link

Previous article

Ideaya Biosciences price target raised to $29 from $26 at Citi

Next article

Lloyds, HSBC, and Barclays: UK Banking Shares in the Spotlight

More articles

Latest article